Skip to main content
Elsevier
View Cart
openUserAccount

Books in Pharmaceuticals

BooksJournals
11-15 of 15 results in All results

Design and Development of New Nanocarriers

  • 1st Edition
  • November 30, 2017
  • Alexandru Mihai Grumezescu
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 3 6 2 7 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 3 6 2 8 - 7
Design and Development of New Nanocarriers focuses on the design and development of new nanocarriers used in pharmaceutical applications that have emerged in recent years. In particular, the pharmaceutical uses of microfluidic techniques, supramolecular design of nanocapsules, smart hydrogels, polymeric micelles, exosomes and metal nanoparticles are discussed in detail. Written by a diverse group of international researchers, this book is a valuable reference resource for those working in both biomaterials science and the pharmaceutical industry.

Pharmaceutical Manufacturing Encyclopedia

  • 3rd Edition
  • January 15, 2013
  • William Andrew William Andrew Publishing
  • English
  • eBook
    9 7 8 - 0 - 8 1 5 5 - 1 8 5 6 - 3
This industry standard encyclopedia on pharmaceutical manufacturing processes has been completely updated to include FDA drugs approved up to the summer of 2004. The encyclopedia gives details for the manufacture of 2226 pharmaceuticals that are being marketed as a trade-named product somewhere in the world. Each entry includes:ò Therapeutic function ò Chemical and common nameò Structural Formulaò Chemical Abstracts Registry no.ò Trade name, manufacturer, country, and year introducedò Raw Materialsò Manufacturing ProcessIn addition, references are also cited under each drug's entry to major pharmaceutical works where additional information can be obtained on synthesis and the pharmacology of the individual products.

Significant Pharmaceuticals Reported in US Patents

  • 1st Edition
  • May 2, 2007
  • Thomas F. DeRosa
  • English
  • eBook
    9 7 8 - 0 - 0 8 - 0 4 8 0 9 1 - 6
Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications.

Over the Counter Pharmaceutical Formulations

  • 1st Edition
  • December 31, 1994
  • David D. Braun
  • English
  • Hardback
    9 7 8 - 0 - 8 1 5 5 - 1 3 4 7 - 6
  • eBook
    9 7 8 - 0 - 8 1 5 5 - 1 8 4 9 - 5
This book presents formulations for over-the-counter (OTC) or nonprescription drugs. The OTC drug formulations in this book are organized according to their therapeutic effect. There are 19 categories of OTC drugs included. Each category is presented in a single chapter that consists of two parts; Part I presents the composition of brand name products, and Part II presents starting or prototype formulations contributed by suppliers of raw materials for OTC drugs. The brand name products are listed alphabetically in Part I of each chapter, followed by the name of the manufacturer, the type and concentration of the active ingredient(s) and the product form(s). It is also customary, but not required, for the manufacturer to list the so-called ""inactive ingredients"" on the label of the product.Part II of each chapter (except chapter 17) includes starting formulations developed by a number of raw material suppliers. Those formulations that are included contain not only the concentration of the active ingredients but also the concentration of the other ingredients and, in most cases, a recommended procedure for mixing the formulation. This book includes 559 brand name formulations of 63 manufacturers and 270 suppliers' suggested formulations for a total of 829 formulations.

Unwanted Effects of Cosmetics and Drugs used in Dermatology

  • 3rd Edition
  • November 25, 1993
  • A.C. de Groot + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 4 - 8 9 7 7 5 - 6
This 3rd edition provides updated information on side effects of cosmetic products, topical and systemic drugs used in dermatology, and other therapeutic modalities used by dermatologists including PUVA therapy and (new in this edition) dermal implants, laser therapy, chemical face peels and cryotherapy.Because of the explosion of new knowledge since the last edition (the 2nd edition of this book was published 8 years ago), the section on cosmetics has largely been rewritten and extended, the section on side effects of systemic drugs used in dermatology has also been expanded, and the index of drugs has been made comprehensive.This book will be of great value to the practising physician who is confronted with a (possible) adverse reaction to a cosmetic or drug used in dermatological practice as well as to those who are scientifically interested, by providing access to recent relevant literature.